Sunil Badve
@Badves
Followers
1K
Following
7K
Statuses
3K
Nephrologist, Conjoint Professor of Medicine @UNSWMedicine @georgeinstitute. 'Science is a way of thinking much more than it is a body of knowledge.' Carl Sagan
Joined November 2012
Excited to share our latest study showing kidney, CV and survival benefits of GLP-1 receptor agonists just published in @TheLancetEndo Time-limited free access 1/
1
8
25
RT @Kidney_Int: A randomized controlled trial evaluated the efficacy and safety of #apixaban for prevention of recurrent thrombosis after #…
0
14
0
RT @JAMA_current: @LRSorce @SebastianPalmqv @NiklasMattsson4 @criticcaredoc @TobyMMaher @AlexSpyropoul Most Viewed JAMA 2024: Medications f…
0
9
0
RT @CircAHA: #ICYMI: GLP-1 RA with and without SGLT2i @mvaduganathan @Badves @RpratleyMD @lheath @brendonneuen
0
9
0
RT @EndocrineToday: 📢 #GLP1 receptor agonists improve both kidney- and heart-related clinical outcomes for individuals with: ▶️ #type2diabe…
0
3
0
RT @brendonneuen: Clear reductions in all outcomes with GLP-1RA: Kidney failure ✅ Major CV events ✅ Heart failure ✅ CV death ✅ All-cause…
0
41
0
RT @TheLancetEndo: New—Effects of #GLP-1 receptor agonists on #kidney and #cardiovascular disease outcomes: a meta-analysis of randomised c…
0
11
0
RT @UNSWMedicine: Popular diabetes drugs like Ozempic can reduce the risk of kidney failure and death due to kidney or cardiovascular cause…
0
1
0
Take home message: as @KatherineTuttl8 says GLP-1 receptor agonists save kidneys and hearts, and lives. #glp1inate 5/5
1
1
3
RT @georgeinstitute: Diabetes and obesity drugs have been found to reduce the risk of kidney failure and protect cardiovascular health in p…
0
2
0
RT @hvanspall: In this subanalysis of the #FLOW #RCT presented by Dr @KatherineTuttl8 at #AHA24, the benefit of #semaglutide in #diabetes w…
0
12
0
RT @NephroSeeker: #kidneywk LBCT first sessions 🎤Moderated by the best can be found ✨@hswapnil and @jardine_meg 👏Need to mention #nephjc…
0
4
0